Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg IV cohorts;Received written FDA Type C meeting minutes; ...

Can this ASX share deliver healthy returns or will things get worse? The post Here are the latest growth forecasts for the CSL share price appeared first on The Motley Fool Australia.

Dianthus Therapeutics (NASDAQ:DNTH) said it has made an “early go” decision to continue its CAPTIVATE Phase 3 trial evaluating claseprubart in chronic inflammatory demyelinating polyneuropathy (CIDP), ...

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializa ...

在谈论肥胖时，我们习惯盯着体重秤、腰围和体脂率。体检报告里，BMI 和腰围往往是最先被圈出来的指标。 你有没有遇到过：体重并不算高，腰也不算粗，却明显感觉到脖子一圈在悄悄变厚，领口变紧，自拍时下颌线模糊。

Detailed price information for Atyr Pharma Inc (ATYR-Q) from The Globe and Mail including charting and trades.